Pathophysiologic characteristics of the activity-stress paradigm in animal models: Inhibitory effect of glucose on these responses

Nutrition Reviews

Volumn 61, Issue 5 II, 2003, Pages

  Takeda, Hiroshi ^a   Tsuji, Minoru ^a   Hayashi, Masaaki ^a   Yamada, Tomoko ^a   Matsumiya, Teruhiko ^a   Koizumi, Miwako ^b   Kimura, Shuichi ^b  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b SHOWA WOMEN'S UNIVERSITY   (Japan)

Author keywords

Activity stress paradigm; Anorexia nervosa; Glucose; Obsessive compulsive disorder

Indexed keywords

ANTIDEPRESSANT AGENT; GLUCOSE; NEUROLEPTIC AGENT; PIMOZIDE; SEROTONIN UPTAKE INHIBITOR;

ANIMAL MODEL; ANOREXIA NERVOSA; CONFERENCE PAPER; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; PATHOPHYSIOLOGY; PEPTIC ULCER; PHYSICAL ACTIVITY; PSYCHOPHARMACOTHERAPY; STRESS; ANIMAL; DISEASE MODEL; EXERCISE; FOOD DEPRIVATION; RAT; REVIEW;

ANIMALIA;

ANIMALS; ANOREXIA NERVOSA; BLOOD GLUCOSE; DISEASE MODELS, ANIMAL; EXERTION; FOOD DEPRIVATION; GLUCOSE; OBSESSIVE-COMPULSIVE DISORDER; RATS; STRESS;

EID: 0037588489     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1301/nr.2003.may.s75-s79     Document Type: Conference Paper

References (29)

1. Paykel ES. Contribution of life events the causation of psychiatric illness. Psychol Med. 1978;8:245-253.
2. Cooke DJ, Hole DJ. The aetiological importance of stressful life events. Br J Psychiatry. 1983;143:397-400.
3. Takeda H, Takada K, Matsumiya T, Shibuya T. The role of brain serotonergic neurons systems in the formation mechanisms of stress adaptation. Meth Find Exp Clin Pharmacol. 1996;18:93-98.
4. Hall JR, Hanford PV. Activity as a function of a restricted feeding schedule. J Comp Physiol Psychol. 1954;47:362-363.
5. Altemus M, Glowa JR, Galliven E, Leong YM, Murphy D. Effects of serotonergic agents on food-restriction-induced hyperactivity. Pharmacol Biochem Behav. 1996;53:123-131.
6. Morrow NS, Schall M, Grijalva CV, et al. Body temperature and wheel running predict survival times in rats exposed to activity-stress. Physiol Behav. 1997; 62:815-825.
7. Iwamoto I, Nishihara M, Takahashi M. VMH lesions reduce excessive running under the activity-stress paradigm in the rats. Physiol Behav. 1999;66:803-808.]
8. Endou M, Yanai K, Sakurai E, Fukudo S, Hongo M, Watanabe T. Food-deprived activity stress decreased the activity of the histaminergic neuron system in rats. Brain Res. 2001;891:32-41.
9. Watanabe K, Hara C, Ogawa N. Feeding conditions and estrous cycle of female rats under the activity-stress procedure from aspects of anorexia nervosa. Physiol Behav. 1992;51:827-832.
10. Hirano M, Tanaka M, Emoto H, et al. Recovery from activity-stress ulcer by ad lib feeding in rats. Physiol Behav. 1998;63:85-89.
11. Lambert KG, Kinsley CH, Jones HE, Klein SL, Peretti SN, Stewart KM. Prenatal stress attenuates ulceration in the activity stress paradigm. Physiol Behav. 1995;57:989-994.
12. 2 receptors are involved etiologically in activity-stress gastric lesion of the rat. J Pharmacol Exp Ther. 1995;273:1001-1007.
13. Katz JL. Long-distance running, anorexia nervosa, and bulimia: a report of two cases. Comp Psychiatry. 1986;27:74-78.
14. Vandereycken W, Pierloot R. Pimozide combined with behavior therapy in the short-term treatment of anorexia nervosa. Acta Psychiatr Scand. 1982;66: 445-450.
15. Johnson C, Stuckey M, Mitchell J. Psychopharmacological treatment of anorexia nervosa and bulimia: Review and synthesis. J Nerv Ment Dis. 1983; 171:524-553.
16. Lambert KG, Porter JH. Pimozide mitigates excessive running in activity-stress paradigm. Physiol Behav. 1992;52:299-304.
17. Halmi K, Eckert E, Marchi P, Sampugnar V, Apple R, Cohen J. Comorbidity of psychiatric diagnoses in anorexia nervosa. Arch Gen Psychiatry. 1991;48: 712-718.
18. Kaye W, Weltzin T, Hsu L, Bulik C, McConaha C, Sobkiewicz T. Patients with anorexia nervosa have elevated scores on the Yale-Brown Obsessive-Compulsive Scale. Int J Eat Disord. 1992;12:57-62.
19. Rubenstein C, Pigott T, Altemus M, L'Heureux F, Gray J, Murphy D. High rates of comorbid OCD patients with bulimia nervosa. Eating Disorders. 1993;1:147-155.
20. Rubenstein C, Pigott T, L'Heureux F, Hill J, Murphy D. A preliminary investigation of the lifetime prevalence of anorexia and bulimia nervosa in patients with obsessive-compulsive disorder. J Clin Psychiatry. 1993;53:309-314.
21. Gold P, Kaye W, Robertson G., Ebert M. Abnormalities in plasma and cerebrospinal fluid arginine vasopressin in patients with anorexia nervosa. N Engl J Med. 1983;308:1117-1123.
22. Hotta M, Shibasaki T, Masuda A, et al. The response of plasma adrenocorticotropin and cortisol to corticotropin-releasing hormone (CRH) and cerebrospinal fluid immunoreactivity CRH in anorexia nervosa patients. J Clin Endocrinol Metab. 1986;62: 319-324.
23. Altemus M, Pigott T, Kalogeras K, et al. Abnormality in the regulation of vasopressin and corticotropin releasing factor secretion in obsessive-compulsive disorder. Arch Gen Psychiatry. 1992;49:9-20.
24. Goodman WK, McDougle CJ, Price LH. Pharmacotherapy of obsessive-compulsive disorder. J Clin Psychiatry. 1992;53:29-37.
25. Gwirtsman H, Guze B, Yager J, Gainsley B. Fluoxetine treatment of anorexia nervosa: an open clinical trial. J Clin Psychiatry. 1990;51:378-382.
26. Perani D, Colombo C, Bressi S, et al. [18F]FDG PET study in obsessive-compulsive disorder. A clinical/ metabolic correlation study after treatment. Br J Psychiatry. 1995;166:244-250.
27. Ko SM. Obsessive compulsive disorder: a neuropsychiatric illness. Singapore Med J. 1996;37:186-188.
28. Sanxena S, Brody AL, Maidment KM, et al. Localized orbitoforntal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder. Neuropsychopharmacology. 1999;21:683-693.
29. Sanxena S, Brody AL, Ho ML, et al. Cerebral metabolism in major depression and obsessive-compulsive disorder occurring separately and concurrently. Biol Psychiatry. 2001;50:159-170.